Delivery Order SPE2DR25D3109-SPE2DR26FT2HT
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit doses) valued at $3,151.29. This is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $6,827.22. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract has a ceiling value of $34,587.54 and is structured as a firm fixed price delivery order with an ultimate completion date of October 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $37,235.86, represents a competitive award with no set-aside designation and is scheduled for completion by December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract valued at $11,751.05, with completion scheduled for December 3, 2025. This is a non-set-aside competitive award to the prime contractor, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $15,435.05 and is scheduled for completion by November 4, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packaging) with a ceiling value of $10,646.62. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of RINVOQ ER 15 mg tablets in unit dose packages of 30 with a contract ceiling value of $40,068.09. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The order is set for ultimate completion by September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $89,150.43. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is set to complete by December 10, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract valued at $26,653.57, with completion scheduled for December 4, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, specifically supporting the Defense Logistics Agency's medical...